Harbour Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Sell
14,438
-16
-0.1% -$1.87K 0.32% 74
2026
Q1
$1.63M Buy
14,454
+1,021
+8% +$118K 0.31% 79
2025
Q4
$1.43M Hold
13,433
0.29% 79
2025
Q3
$1.18M Sell
13,433
-278
-2% -$22.9K 0.24% 95
2025
Q2
$1.13M Sell
13,711
-459
-3% -$36.5K 0.24% 97
2025
Q1
$1.22M Sell
14,170
-18,839
-57% -$1.76M 0.3% 83
2024
Q4
$3.27M Sell
33,009
-3,225
-9% -$332K 0.73% 38
2024
Q3
$4M Sell
36,234
-30
-0.1% -$3.56K 0.92% 30
2024
Q2
$4.64M Buy
36,264
+60
+0.2% +$7.73K 1.1% 23
2024
Q1
$4.72M Buy
36,204
+69
+0.2% +$8.51K 1.17% 23
2023
Q4
$4.15M Buy
36,135
+223
+0.6% +$23.1K 1.14% 24
2023
Q3
$3.7M Buy
35,912
+840
+2% +$90.5K 1.11% 24
2023
Q2
$4.01M Sell
35,072
-827
-2% -$93.9K 1.18% 21
2023
Q1
$3.82M Buy
35,899
+1,894
+6% +$204K 1.16% 24
2022
Q4
$3.78M Sell
34,005
-504
-1% -$51.5K 1.27% 22
2022
Q3
$3.12M Sell
34,509
-165
-0.5% -$14.7K 1.08% 26
2022
Q2
$3.16M Buy
34,674
+105
+0.3% +$9.31K 1.03% 28
2022
Q1
$2.84M Buy
34,569
+310
+0.9% +$24.4K 0.78% 43
2021
Q4
$2.63M Buy
34,259
+231
+0.7% +$18.4K 0.65% 51
2021
Q3
$2.56M Buy
34,028
+750
+2% +$57K 0.67% 49
2021
Q2
$2.59M Sell
33,278
-997
-3% -$74.2K 0.7% 45
2021
Q1
$2.52M Buy
34,275
+446
+1% +$32.9K 0.74% 42
2020
Q4
$3K Buy
33,829
+708
+2% +$54.1K 1.49% 28
2020
Q3
$2.62M Buy
33,121
+512
+2% +$40.1K 0.96% 32
2020
Q2
$2.41M Buy
32,609
+1,965
+6% +$148K 0.98% 30
2020
Q1
$2.25M Buy
30,644
+1,405
+5% +$110K 1.14% 25
2019
Q4
$2.54M Buy
29,239
+440
+2% +$36.1K 0.97% 28
2019
Q3
$2.31M Buy
28,799
+2,578
+10% +$207K 0.98% 29
2019
Q2
$2.1M Buy
26,221
+383
+1% +$29.3K 0.9% 32
2019
Q1
$2.05M Buy
25,838
+303
+1% +$22.7K 0.91% 29
2018
Q4
$1.86M Buy
25,535
+226
+0.9% +$16K 0.92% 29
2018
Q3
$1.71M Buy
25,309
+647
+3% +$41.2K 0.69% 41
2018
Q2
$1.42M Buy
24,662
+3,616
+17% +$204K 0.61% 52
2018
Q1
$1.09M Buy
21,046
+11,157
+113% +$603K 0.47% 80
2017
Q4
$531K Sell
9,889
-2,681
-21% -$149K 0.22% 133
2017
Q3
$768K Buy
+12,570
New +$762K 0.33% 104
2017
Q2
Sell
-2,090
Closed -$127K 463
2017
Q1
$127K Buy
+2,090
New +$127K 0.06% 259
2016
Q4
Sell
-2,247
Closed -$134K 229
2016
Q3
$134K Buy
+2,247
New +$131K 0.08% 221

Other funds holding MRK

Harbour Capital Advisors's MRK Position: Q2 2026 in Review

Harbour Capital Advisors reduced its Merck (MRK) stake by 0.11% in Q2 2026, selling an estimated $1.87K and leaving 14,438 shares worth $1.78M. The position accounts for 0.32% of the portfolio, ranked #74.

Harbour Capital Advisors first reported a position in MRK in Q3 2016 and has held it in 38 quarters since. The position peaked at $4.72M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Harbour Capital Advisors held 14,438 shares of Merck worth $1.78M as of Q2 2026.
  • Harbour Capital Advisors sold 16 Merck shares in Q2 2026, an estimated $1.87K.
  • Merck made up 0.32% of Harbour Capital Advisors's portfolio in Q2 2026, its #74 holding.
  • Harbour Capital Advisors first reported a position in Merck in Q3 2016 and has held it in 38 quarters since.
  • Harbour Capital Advisors's Merck position peaked at $4.72M in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.